Code of Ethics of the Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan

The Code of Ethics (hereinafter referred to as the “Code”) of the Association of International Pharmaceutical Manufacturers (hereinafter referred to as “AIPM”) of the Republic of Kazakhstan had been developed on the basis of international marketing practices codes adopted in the research pharmaceutical industry with view to the requirements of the legislation of the Republic of Kazakhstan, and sets out the ethical standards, which all members of the AIPM are required to follow when engaging in Promotion and Marketing of Pharmaceutical Products in the Republic of Kazakhstan.

The provisions of the Code are intended to help AIPM members develop and apply standards of transparent and responsible Promotion and Marketing, taking into account the interests of public health in the Republic of Kazakhstan, and also serve as a tool for addressing any ethical issues between AIPM members in the event of disputes.

 

The Code represents a number of additional fundamental principles that guide AIPM members when carrying out Marketing and Promotion of Pharmaceutical Products in the Republic of Kazakhstan, as the legislation of the Republic of Kazakhstan in this area always takes precedence.

The Code prescribes that responsibility and control over compliance with high standards in the Promotion of Pharmaceutical Products in the Republic of Kazakhstan rests with the members of the AIPM. All AIPM members must make correct and conscientious decisions, first of all, focusing on the interests of their Patient. Promotion of Pharmaceutical Products in violation of the Code is unacceptable.

All AIPM members undertake not to distribute any materials that diverge from the provisions and principles of this Code, and to avoid any actions in the field of Marketing of Pharmaceutical Products that are contrary to this document. Respect for the individual, patient focus, transparency and adherence to ethical standards are the values that should underlie everything that AIPM members do. The management of [each company - a member of the AIPM (hereinafter referred to as the “Company”)] is obliged to ensure the activities of the Company in accordance with the requirements of the legislation of the Republic of Kazakhstan and this Code.

Management undertakes to take action in relation to each identified and proven violation. Each newly joined AIPM Company is obliged to ensure compliance with the provisions of the Code and conduct introductory training on the provisions of this Code for all employees and persons engaged by the Company within 6 months from the date of joining the AIPM, and make new employees and persons engaged by the Company aware thereof. This Code, as well as all any amendments made to the Code, come into force for the Company after 6 months from the date of their adoption.

This Code, as well as any amendments and supplements thereto, are approved 72 by a resolution of the AIPM General Meeting. Any amendments and supplements to this Code may be made at the initiative of any Company.

THE 2024 EDITION OF THE CODE OF ETHICS OF THE ASSOCIATION OF INTERNATIONAL PHARMACEUTICAL MANUFACTURERS IN THE REPUBLIC OF KAZAKHSTAN CAN BE READ HERE.